Healthy glucose levels are a key marker of biological age
Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk was published in Nature Cardiovascular Research in April 2024
Frequently Asked Questions Related reading: Sourcing GLP-1s for Weight-Loss and Aesthetics Clinics in 2026 The 2026 IV Therapy Sourcing Playbook: How Compliant Clinics Buy Smarter 503A vs
He reported severe brain fog, gastrointestinal distress, poor sleep, irritability, cognitive dysfunction, and what he called a "scorched" digestive system
Retatrutide got less spectacular between June and July
These are typically most common during the dose escalation phase and should be monitored by a healthcare professional (15,16,17)